Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Amylyx Pharmaceuticals, Inc. (AMLX)

28.73 +0.66 (+2.35%)
As of 11:15:06 AM EDT. Market Open.
Trade AMLX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
87,371
380,786
22,230
Cost of Revenue
--
0
124,633
25,441
2,993
Gross Profit
--
0
-37,262
355,345
19,237
Operating Expense
162,103
153,291
218,415
316,543
220,578
Operating Income
-162,103
-153,291
-255,677
38,802
-201,341
Net Non Operating Interest Income Expense
10,004
9,302
13,809
16,155
4,291
Other Income Expense
53
-700
-60,268
-660
-551
Pretax Income
-152,046
-144,689
-302,136
54,297
-197,601
Tax Provision
--
46
-393
5,026
774
Net Income Common Stockholders
-152,092
-144,735
-301,743
49,271
-198,375
Diluted NI Available to Com Stockholders
-152,092
-144,735
-301,743
49,271
-198,375
Basic EPS
-1.41
-1.53
-4.43
0.73
-3.39
Diluted EPS
-1.41
-1.53
-4.43
0.70
-3.39
Basic Average Shares
106,292.83
94,565.57
68,142.16
67,234.47
58,495.59
Diluted Average Shares
106,292.83
94,565.57
68,142.16
69,991.34
58,495.59
Total Operating Income as Reported
-162,103
-153,291
-314,731
38,802
-201,341
Total Expenses
162,103
153,291
343,048
341,984
223,571
Net Income from Continuing & Discontinued Operation
-152,092
-144,735
-301,743
49,271
-198,375
Normalized Income
-152,092
-144,735
-242,748.05
49,271
-198,375
Interest Income
10,004
9,302
13,809
16,155
4,291
Net Interest Income
10,004
9,302
13,809
16,155
4,291
EBIT
-162,103
-153,291
-255,677
38,802
-201,341
EBITDA
-161,734
-152,766
-254,773
39,890
-200,854
Reconciled Cost of Revenue
--
0
124,633
25,441
2,993
Reconciled Depreciation
369
525
904
1,088
487
Net Income from Continuing Operation Net Minority Interest
-152,092
-144,735
-301,743
49,271
-198,375
Total Unusual Items Excluding Goodwill
0
0
-59,054
0
--
Total Unusual Items
0
0
-59,054
0
--
Normalized EBITDA
-161,734
-152,766
-195,719
39,890
-200,854
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
-59.05
0
0
12/31/2022 - 1/7/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: